Platelet release protein which inhibits plasminogen activators.

N A Booth, J A Anderson, B Bennett

An inhibitor of plasminogen activator has been identified in human platelets by the technique of sodium dodecyl sulphate polyacrylamide gel electrophoresis and zymography. The inhibitor has a molecular weight of about 40 000 and is distinct from known plasma protease inhibitors. It is associated almost exclusively with platelets, with only trace amounts in platelet free plasma. The inhibitor is released during platelet aggregation or in vitro coagulation. This inhibitor inhibits both tissue type plasminogen activator and urokinase but has no effect on plasmin. It forms a 1:1 complex with tissue type plasminogen activator, which retains activity detectable under the analytical conditions used. A similar complex with urokinase either forms less readily or retains less activity.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Rudnicka, A. R., Rumley, A., Lowe, G. D.O., Strachan, D. P. (2007). Diurnal, Seasonal, and Blood-Processing Patterns in Levels of Circulating Fibrinogen, Fibrin D-Dimer, C-Reactive Protein, Tissue Plasminogen Activator, and von Willebrand Factor in a 45-Year-Old Population. Circulation 115: 996-1003 [Abstract] [Full Text]  
• Lang, I. M., Chuang, T. L., Barbas, C. F. III, Schleef, R. R. (1996). Purification of Storage Granule Protein-23. A NOVEL PROTEIN IDENTIFIED BY PHAGE DISPLAY TECHNOLOGY AND INTERACTION WITH TYPE I PLASMINOGEN ACTIVATOR INHIBITOR. J. Biol. Chem. 271: 30126-30135 [Abstract] [Full Text]  
• Lang, I. M., Schleef, R. R. (1996). Calcium-dependent Stabilization of Type I Plasminogen Activator Inhibitor within Platelet alpha-Granules. J. Biol. Chem. 271: 2754-2761 [Abstract] [Full Text]